Courtesy of Benzinga.
IMS Health Holdings, Inc. (“IMS Health”) (NYSE: IMS) today announced the launch of a secondary public offering of 45.8 million shares of its common stock by existing shareholders affiliated with TPG Global, LLC, Canada Pension Plan Investment Board and Leonard Green & Partners, L.P., of which IMS Health intends to repurchase a number of shares having an aggregate value of $300 million. The selling shareholders have granted the underwriters an option to purchase up to an additional 6.87 million shares of common stock. IMS Health is not offering any stock in this transaction and will not receive any proceeds from the sale of the shares by the selling shareholders.
Goldman, Sachs & Co., J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC are acting as joint book-running managers and as representatives of the underwriters for the offering. In addition, BofA Merrill Lynch, Wells Fargo Securities, Barclays, Deutsche Bank Securities and HSBC are joint book-running managers for the offering and TPG Capital BD, LLC, SunTrust Robinson Humphrey, Mizuho Securities, RBC Capital Markets, Piper Jaffray, William Blair & Company L.L.C., Leerink Partners, Stifel, Fifth Third Bank and Topeka Capital Markets are acting as co-managers for the offering.
An automatic shelf registration statement (including a prospectus) relating to the offering of common stock was filed with the Securities and Exchange Commission (SEC) on May 4, 2015 and became effective upon filing. Before you invest, you should read the registration statement, prospectus and other documents IMS Health has made available with the SEC for information about IMS Health and the offering. You may obtain these documents free of charge by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, copies of the prospectus and accompanying prospectus supplement, when available, may be obtained from: Goldman, Sachs & Co., Attention: Prospectus Department, 200 West Street, New York, NY 10282, or by telephone at (866) 471-2526, facsimile at (212) 902-9316, or e-mail at prospectus-ny@ny.email.gs.com; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by telephone at (866) 803-9204; or Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
